Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1988
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A02BC01
|
| gptkbp:brand |
gptkb:omeprazole
gptkb:Prilosec Antra Zegerid |
| gptkbp:chemicalFormula |
C17H19N3O3S
|
| gptkbp:contraindication |
hypersensitivity to omeprazole
|
| gptkbp:discoveredBy |
gptkb:Astra_AB
|
| gptkbp:drugClass |
proton pump inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Losec
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:marketedIn |
many countries worldwide
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain headache |
| gptkbp:usedFor |
treatment of peptic ulcer disease
treatment of Zollinger-Ellison syndrome treatment of gastroesophageal reflux disease |
| gptkbp:bfsParent |
gptkb:omeprazole
|
| gptkbp:bfsLayer |
6
|